Semma Therapeutics' Unattributed VC Round

Semma Therapeutics raised a round of funding on March 22, 2017. Investors include JDRF.

Semma Therapeutics is a biopharmaceutical company developing Stem Cell-derived Islet therapy for type 1 diabetes.…

Articles about Semma Therapeutics' Unattributed VC Round: